Understanding the bipartisan Senate Finance prescription drug reform package

On July 25, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019 was approved by the Senate Finance Committee by a 19-9 vote, with small modifications to the initial Chairman’s mark. Taken together, the legislation seeks to address many issues with prescription drug markets and coverage that affect Medicare and its beneficiaries, focusing on lowering … Continue reading Understanding the bipartisan Senate Finance prescription drug reform package